文献速递皮肤肿瘤

LPCAT1通过EGFR介导的蛋白激酶B/p38MAPK信号通路促进皮肤鳞状细胞癌

LPCAT1 Promotes Cutaneous Squamous Cell Carcinoma via EGFR-Mediated Protein Kinase B/p38MAPK Signaling Pathways.
PubMed 文献 · J Invest Dermatol · 2021-08-04

本研究探讨LPCAT1在皮肤鳞状细胞癌(cSCC)中的作用及分子机制,发现LPCAT1在cSCC组织和细胞系中表达上调,体外实验表明其促进细胞增殖、抑制凋亡、加速上皮间质转化并增强转移,机制上通过EGFR/蛋白激酶B和EGFR/p38MAPK通路介导致癌效应,异种移植小鼠模型验证了上述结果。

要点

  • LPCAT1在cSCC组织和细胞系中表达上调。
  • LPCAT1促进cSCC细胞增殖、抗凋亡、上皮间质转化和转移。
  • LPCAT1通过EGFR/蛋白激酶B和EGFR/p38MAPK通路发挥致癌作用。

核心结论

  • LPCAT1通过EGFR介导的蛋白激酶B和p38MAPK信号通路促进cSCC进展,可能作为治疗干预靶点。

研究设计与样本

  • 研究检测了cSCC组织和细胞系中LPCAT1的表达,并进行体外功能获得与缺失实验及异种移植小鼠模型验证。

主要发现

  • LPCAT1在cSCC组织和细胞系中表达上调。
  • LPCAT1促进cSCC细胞增殖、保护细胞免于凋亡、加速上皮间质转化并增强细胞转移。
  • LPCAT1调控EGFR信号,其致癌效应由EGFR/蛋白激酶B和EGFR/p38MAPK通路介导。
  • 异种移植小鼠模型巩固了上述结果。

临床怎么用

  • LPCAT1可能作为cSCC治疗干预的潜在靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cutaneous squamous cell carcinoma (cSCC) is the second most common form of skin cancer. LPCAT1, a lysophosphatidylcholine acyltransferase, takes a center stage in membrane lipid remodeling. LPCAT1 is elevated in several cancers and contributes to cancer development. However, its role and molecular mechanisms in cSCC remain to be elucidated. In this study, we found that LPCAT1 was upregulated in cSCC tissues and in cell lines. In vitro, loss-of-function and gain-of-function experiments demonstrated that LPCAT1 facilitated cSCC cell proliferation, protected cells against apoptosis, accelerated epithelial‒mesenchymal transition, and enhanced cell metastasis. Mechanistically, LPCAT1 regulated EGFR signaling. The oncogenic effect of LPCAT1 was mediated by EGFR/protein kinase B and EGFR/p38MAPK pathways in cSCC. Using the xenograft mouse model, we consolidated the results mentioned earlier. In conclusion, LPCAT1 contributed to cSCC progression through EGFR-mediated protein kinase B and p38MAPK signaling pathways. LPCAT1 may serve as a target for therapeutic intervention in cSCC.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Huang Y, Wang Y, Wang Y, et al. LPCAT1 Promotes Cutaneous Squamous Cell Carcinoma via EGFR-Mediated Protein Kinase B/p38MAPK Signaling Pathways. J Invest Dermatol. 2021. PMID: 34358528. doi:10.1016/j.jid.2021.07.163

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。